Duality Biotherapeutics stock more than doubled on its Hong Kong debut on Tuesday, after the Chinese firm raised $213 million in an initial public offering launched the day financial markets reacted savagely to a U.S. tariffs announcement.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
